首页> Clinical lymphoma, myeloma & leukemia> Association of Thrombocytopenia With Disease Burden, High-Risk Cytogenetics, and Survival in Newly Diagnosed Multiple Myeloma Patients Treated With Novel Therapies.

Association of Thrombocytopenia With Disease Burden, High-Risk Cytogenetics, and Survival in Newly Diagnosed Multiple Myeloma Patients Treated With Novel Therapies.

导出 LinkOut

翻译打印收藏纠错

第一作者： Charalampos,Charalampous

第一单位： Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN.

作者： Charalampos,Charalampous ^[1] ; Utkarsh,Goel ^[1] ; Prashant,Kapoor ^[1] ; Moritz,Binder ^[1] ; Francis,Buadi ^[1] ; David,Dingli ^[1] ; Angela,Dispenzieri ^[1] ; Amie,Fonder ^[1] ; Morie,Gertz ^[1] ; Wilson,Gonsalves ^[1] ; Suzanne,Hayman ^[1] ; Miriam,Hobbs ^[1] ; Yi Lisa,Hwa ^[1] ; Taxiarchis,Kourelis ^[1] ; Martha,Lacy ^[1] ; Nelson,Leung ^[2] ; Yi,Lin ^[1] ; Rahma,Warsame ^[1] ; Robert A,Kyle ^[1] ; Vincent,Rajkumar ^[1] ; Shaji K,Kumar ^[3]

作者单位： Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN. ^[1] Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN. ^[2] Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN. Electronic address: kumar.shaji@mayo.edu. ^[3]

关键词 FISH Independent factor Platelets Prognosis Risk stratification